Anders Erik Astrup Dahm

1.7k citations

56 papers · 1.1k indexed · h-index 18

Hematology top 2%
Internal Medicine top 1%
Cardiology and Cardiovascular Medicine top 10%
Genetics top 5%
Public Health, Environmental and Occupational Health top 10%

Co-authors: Per Morten Sandset Frits R. Rosendaal Astrid van Hylckama Vlieg Rogier M. Bertina Bjørn Bendz Jan Rosing Anne Flem Jacobsen R M Bertina
Topics: Venous Thromboembolism Diagnosis and Management (29 papers)Blood Coagulation and Thrombosis Mechanisms (20 papers)Coagulation, Bradykinin, Polyphosphates, and Angioedema (12 papers)
Cited by: Internal Medicine Hematology Genetics
Journals: SHILAP Revista de lepidopterologíaBlood PLoS ONE
Partner nations: Norway Netherlands United States

In The Last Decade

Anders Erik Astrup Dahm

53 papers receiving 1.0k citations

Peers

Countries citing papers authored by Anders Erik Astrup Dahm

Since Specialization

Citations

This map shows the geographic impact of Anders Erik Astrup Dahm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Erik Astrup Dahm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Erik Astrup Dahm more than expected).

Fields of papers citing papers by Anders Erik Astrup Dahm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Erik Astrup Dahm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Erik Astrup Dahm. The network helps show where Anders Erik Astrup Dahm may publish in the future.

Co-authorship network of co-authors of Anders Erik Astrup Dahm

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Erik Astrup Dahm. A scholar is included among the top collaborators of Anders Erik Astrup Dahm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Erik Astrup Dahm. Anders Erik Astrup Dahm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ruxolitinib in patients with polycythemia vera resistant and/or intolerant to hydroxyurea: European observational study 2023 ·European Journal Of Haematology ·(unknown),Heinz Gisslinger,Valerio De Stefano,Vincenzo Accurso,Alessandra Iurlo,Timothy Devos,Miklós Egyed,Éric Lippert,(unknown),Nathan Cantoni,Anders Erik Astrup Dahm,Damianos Sotiropoulos,(unknown),(unknown),Amir Iqbal,P. Di Matteo,Mike W. Zuurman,Peter A.W. te Boekhorst	1
2	OC 03.5 Arterial Events in Cancer Patients Treated with Apixaban for Venous Thrombosis 2023 ·Research and Practice in Thrombosis and Haemostasis ·(unknown),(unknown),(unknown),Tone Enden,(unknown),Herish Garresori,E Jacobsen,Peter Kildeberg Paulsen,Alina Carmen Porojnicu,Anne Hansen Ree,Dag Torfoss,(unknown),(unknown),Waleed Ghanima,Per Morten Sandset,Anders Erik Astrup Dahm	1
3	Low Diagnostic Accuracy and Inter-Observer Agreement on CT and MRI in Diagnosis of Spinal Fractures in Multiple Myeloma 2021 ·Hematology Reports ·(unknown),(unknown),(unknown),Jonn Terje Geitung,Anders Erik Astrup Dahm	2
4	Venous thrombosis with oral postmenopausal hormone therapy: Roles of activated protein C resistance and tissue factor pathway inhibitor 2021 ·Journal of Thrombosis and Haemostasis ·(unknown),Sowmya Vasan,Mary Cushman,Anders Erik Astrup Dahm,Per Morten Sandset,Jacques E. Rossouw,Astrid van Hylckama Vlieg	6
5	Bias in animal studies of estrogen effects on cardiovascular disease: A systematic review and meta‐analysis 2021 ·Research and Practice in Thrombosis and Haemostasis ·(unknown),(unknown),Anders Erik Astrup Dahm	3
6	Safety of D‐dimer testing as a stand‐alone test for the exclusion of deep vein thrombosis as compared with other strategies 2018 ·Journal of Thrombosis and Haemostasis ·(unknown),Hilde Skuterud Wik,Anders Erik Astrup Dahm,(unknown),Jostein Gleditsch,(unknown),Frederikus A. Klok,Waleed Ghanima	22
7	Rivaroxaban Versus Warfarin for the Prevention of Post-Thrombotic Syndrome 2018 ·Journal of Vascular Surgery Venous and Lymphatic Disorders ·(unknown),Anders Erik Astrup Dahm,Hilde Skuterud Wik,Lars‐Petter Jelsness‐Jørgensen,Per Morten Sandset,Waleed Ghanima	0
8	Relationship between sex hormone binding globulin and blood coagulation in women on postmenopausal hormone treatment 2018 ·Blood Coagulation & Fibrinolysis ·(unknown),Anders Erik Astrup Dahm,Else Høibraaten,Cathrine M. Lofthus,Marie‐Christine Mowinckel,Per Morten Sandset	8
9	Rivaroxaban versus warfarin for the prevention of post-thrombotic syndrome 2018 ·Thrombosis Research ·(unknown),Anders Erik Astrup Dahm,Hilde Skuterud Wik,Lars‐Petter Jelsness‐Jørgensen,Per Morten Sandset,Waleed Ghanima	36
10	Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial 2017 ·PLoS ONE ·Christian Prebensen,Marius Trøseid,Thor Ueland,Anders Erik Astrup Dahm,Per Morten Sandset,Ingeborg S. Aaberge,K. Waalen,Anne Ma Dyrhol‐Riise,Kjetil Taskén,Dag Kvale	8
11	A novel hypoxia response element regulates oxygen-related repression of tissue factor pathway inhibitor in the breast cancer cell line MCF-7 2017 ·Thrombosis Research ·(unknown),Grethe Skretting,(unknown),Benedicte Stavik,Anders Erik Astrup Dahm,Kristine Kleivi Sahlberg,Sandip M. Kanse,Nina Iversen,Per Morten Sandset	18
12	Effect of hypoxia on tissue factor pathway inhibitor expression in breast cancer 2015 ·Journal of Thrombosis and Haemostasis ·(unknown),(unknown),Benedicte Stavik,Anders Erik Astrup Dahm,Sandip M. Kanse,Yongmei M. Jin,(unknown),Kristine Kleivi Sahlberg,Nina Iversen,Grethe Skretting,Per Morten Sandset	20
13	Adaptation of Trustworthy Guidelines Developed Using the GRADE Methodology 2014 ·CHEST Journal ·Annette Kristiansen,Linn Brandt,Thomas Agoritsas,Elie A. Akl,Eivind Berge,Johan Bondi,Anders Erik Astrup Dahm,Lars‐Petter Granan,Sigrun Halvorsen,(unknown),Anne Flem Jacobsen,Eva‐Marie Jacobsen,Ignacio Neumann,Per Morten Sandset,(unknown),Arnljot Tveit,Trond Vartdal,Gordon Guyatt,Per Olav Vandvik	16
14	A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women 2012 ·Thrombosis Research ·Anders Erik Astrup Dahm,(unknown),Jelle J. Goeman,Ole Kristoffer Olstad,Reidun Øvstebø,Peter Kierulf,Marie‐Christine Mowinckel,Grethe Skretting,Per Morten Sandset	10
15	Differential haemostatic risk factors for pregnancy-related deep-vein thrombosis and pulmonary embolism 2012 ·Thrombosis and Haemostasis ·Anders Erik Astrup Dahm,Anne Flem Jacobsen,Leiv Sandvik,Per Morten Sandset,(unknown)	14
16	An Exploratory Trial of Cyclooxygenase Type 2 Inhibitor in HIV-1 Infection: Downregulated Immune Activation and Improved T Cell-Dependent Vaccine Responses 2011 ·Journal of Virology ·Frank Olav Pettersen,(unknown),Anders Erik Astrup Dahm,Ingeborg S. Aaberge,Andreas Lind,(unknown),Einar Martin Aandahl,Per Morten Sandset,Kjetil Taskén,Dag Kvale	53
17	Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor 2008 ·Journal of Thrombosis and Haemostasis ·Hubertus A.A.M. van Vliet,R M Bertina,Anders Erik Astrup Dahm,Frits R. Rosendaal,Jan Rosing,Per Morten Sandset,Frans M. Helmerhorst	60
18	The association between protein S levels and anticoagulant activity of tissue factor pathway inhibitor type 1 2008 ·Journal of Thrombosis and Haemostasis ·Anders Erik Astrup Dahm,Per Morten Sandset,Frits R. Rosendaal	21
19	Tissue factor pathway inhibitor anticoagulant activity: risk for venous thrombosis and effect of hormonal state 2005 ·British Journal of Haematology ·Anders Erik Astrup Dahm,Frits R. Rosendaal,Trine Opstad Andersen,Per Morten Sandset	10
20	Angiogenesis and Hemostasis in Hematological Neoplasias 2005 ·Current Drug Targets ·Helene F. S. Negaard,Anders Erik Astrup Dahm,Per Morten Sandset,Per Ole Iversen,(unknown)	4

About Anders Erik Astrup Dahm

Anders Erik Astrup Dahm is a scholar working on Internal Medicine, Hematology and Genetics, having authored 56 papers that have together received 1.1k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (29 papers), Blood Coagulation and Thrombosis Mechanisms (20 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (12 papers). The work is most often cited by research in Internal Medicine (388 citations), Hematology (531 citations) and Genetics (177 citations). Anders Erik Astrup Dahm has collaborated with scholars based in Norway, Netherlands and United States. Frequent co-authors include Per Morten Sandset, Frits R. Rosendaal, Astrid van Hylckama Vlieg, Rogier M. Bertina, Bjørn Bendz, Jan Rosing, Anne Flem Jacobsen, R M Bertina, Frans M. Helmerhorst and Hubertus A.A.M. van Vliet. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact